上述数据使用的会计准则为 US_GAAP。$Champions Oncology (CSBR.US)$The financial report will be released after the market closes on December 11, please pay attention, investors.
How was the previous performance?
$Champions Oncology (CSBR.US)$In Q1 2025, the revenue was 14.061 million USD, net income was 1.313 million USD, and the eps was 0.09 USD.
In Q2 2024, the revenue was 11.573 million USD, net income was -2.071 million USD, and the eps was -0.15 USD.
The above data is based on the US_GAAP accounting standards.
Futubull reminder:
1. There is no strict requirement for the division of accounting year for Hong Kong and US listed companies, which is entirely determined by the company itself. Therefore, each financial reporting period can be used as the company's annual report deadline, rather than using the calendar year as the fiscal year.
2. Generally, the company will hold a financial report conference on the above financial report release date or nearby dates. At that time, the company's management will discuss and explain the latest quarterly financial data and operational situation, and communicate with investors, analysts, media, etc.
Investors can participate through offline meetings or online teleconferences, etc.
